AB0676 CROSS-EVALUATIONS OF DISEASE ACTIVITIES AND JOINT AFFECT RATIO AFTER BIOLOGICAL OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS USING THE SIMPLIFIED DISEASE ACTIVITY INDEX SCORE AND THE JOINT INDEX VECTOR SCORES

Abstract

Background:Joint Index Vector (JIV) was developed by Nishiyama1), which evaluates only joint involvement in the whole body of the patient with rheumatoid arthritis (RA), presenting a 3-dimensional coordinate axis. This...